Clinical Trial Update: 68Ga-FAPI-46 PET for Imaging of FAP Expressing Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating 68Ga-FAPI-46 PET imaging for cancers expressing fibroblast activation protein (FAP).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tumor Solid

Drugs mentioned

• 68Ga-FAPI-46 (Gallium-68-labeled FAPI-46)

Snippet

Sponsor: University Hospital, Essen | Conditions: Tumor, Solid | Phase 2 | Status: COMPLETED